BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 25419074)

  • 21. Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?
    Sioulas VD; Schiavone MB; Kadouri D; Zivanovic O; Roche KL; O'Cearbhaill R; Abu-Rustum NR; Levine DA; Sonoda Y; Gardner GJ; Leitao MM; Chi DS
    Gynecol Oncol; 2017 Apr; 145(1):15-20. PubMed ID: 28238354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
    da Costa Miranda V; de Souza Fêde ÂB; Dos Anjos CH; da Silva JR; Sanchez FB; da Silva Bessa LR; de Paula Carvalho J; Filho EA; de Freitas D; Del Pilar Estevez Diz M
    Gynecol Oncol; 2014 Feb; 132(2):287-91. PubMed ID: 24333355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage III-IV Ovarian Serous Carcinoma.
    Kawaguchi R; Tanase Y; Haruta S; Nagai A; Yoshida S; Furukawa N; Ooi H; Kobayashi K
    Case Rep Oncol; 2012 Jan; 5(1):173-80. PubMed ID: 22666209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas.
    Horn LC; Kafkova S; Leonhardt K; Kellner C; Einenkel J
    Int J Gynecol Pathol; 2013 Jul; 32(4):339-44. PubMed ID: 23722505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary peritoneal and ovarian cancers: an epidemiological comparative analysis.
    Grant DJ; Moorman PG; Akushevich L; Palmieri RT; Bentley RC; Schildkraut JM
    Cancer Causes Control; 2010 Jul; 21(7):991-8. PubMed ID: 20309725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review.
    Pentheroudakis G; Pavlidis N
    Crit Rev Oncol Hematol; 2010 Jul; 75(1):27-42. PubMed ID: 19897383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004.
    Goodman MT; Shvetsov YB
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):132-9. PubMed ID: 19124490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.
    Carlson JW; Miron A; Jarboe EA; Parast MM; Hirsch MS; Lee Y; Muto MG; Kindelberger D; Crum CP
    J Clin Oncol; 2008 Sep; 26(25):4160-5. PubMed ID: 18757330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical identification of primary peritoneal serous cystadenocarcinoma mimicking advanced colorectal carcinoma: a case report.
    von Riedenauer WB; Janjua SA; Kwon DS; Zhang Z; Velanovich V
    J Med Case Rep; 2007 Nov; 1():150. PubMed ID: 18036260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
    Heintz AP; Odicino F; Maisonneuve P; Quinn MA; Benedet JL; Creasman WT; Ngan HY; Pecorelli S; Beller U
    Int J Gynaecol Obstet; 2006 Nov; 95 Suppl 1():S161-92. PubMed ID: 17161157
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular similarities between primary peritoneal and primary ovarian carcinomas.
    Chen LM; Yamada SD; Fu YS; Baldwin RL; Karlan BY
    Int J Gynecol Cancer; 2003; 13(6):749-55. PubMed ID: 14675310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary peritoneal carcinoma: a report of twelve cases and a review of the literature.
    Cormio G; Di Vagno G; Di Gesù G; Mastroianni M; Melilli GA; Vimercati A; Putignano G; Loverro G; Selvaggi L
    Gynecol Obstet Invest; 2000; 50(3):203-6. PubMed ID: 11014956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis.
    Schorge JO; Muto MG; Lee SJ; Huang LW; Welch WR; Bell DA; Keung EZ; Berkowitz RS; Mok SC
    Cancer Res; 2000 Mar; 60(5):1361-4. PubMed ID: 10728699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening.
    Karlan BY; Baldwin RL; Lopez-Luevanos E; Raffel LJ; Barbuto D; Narod S; Platt LD
    Am J Obstet Gynecol; 1999 Apr; 180(4):917-28. PubMed ID: 10203660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with platinum-paclitaxel chemotherapy in the initial management of papillary serous carcinoma of the peritoneum.
    Kennedy AW; Markman M; Webster KD; Kulp B; Peterson G; Rybicki LA; Belinson JL
    Gynecol Oncol; 1998 Nov; 71(2):288-90. PubMed ID: 9826473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations.
    Schorge JO; Muto MG; Welch WR; Bandera CA; Rubin SC; Bell DA; Berkowitz RS; Mok SC
    J Natl Cancer Inst; 1998 Jun; 90(11):841-5. PubMed ID: 9625172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary.
    Bloss JD; Liao SY; Buller RE; Manetta A; Berman ML; McMeekin S; Bloss LP; DiSaia PJ
    Gynecol Oncol; 1993 Sep; 50(3):347-51. PubMed ID: 8406199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
    Mazoujian G; Pinkus GS; Davis S; Haagensen DE
    Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary peritoneal carcinoma: regional cancer institute experience.
    Ifthikar AM; Rathod PS; Shruthi S; Pallavi VR; Shobha K; Shankaranand B; Umadevi K; Bafna UD
    Indian J Surg Oncol; 2014 Sep; 5(3):232-6. PubMed ID: 25419074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.